CHELSEA VANCE: Open Payments
NPI 1043964927 · DIXON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 35 payments from 12 companies in 2025. Trend: 2023 $374 · 2024 $663 · 2025 $507
Food & beverage: $507
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 17 | $200 |
| ABBVIE INC. | 4 | $68 |
| Novo Nordisk Inc | 3 | $51 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Axsome Therapeutics, Inc. | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Ardelyx, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| PFIZER INC. | 1 | $16 |
Products named: Azstarys, VRAYLAR, TRELEGY ELLIPTA, Auvelity, FANAPT, CAPLYTA, IBSRELA, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
